Antipsychotic

Expanded surveys will focus on staffing, MDS coding

Expanded surveys will focus on staffing, MDS coding

By

Special surveys to determine Minimum Data Set coding accuracy and nursing home staffing levels will occur nationwide in 2015, the Centers for Medicare & Medicaid Services announced in an Oct. 31 memorandum. A five-state pilot of the focused surveys concluded in August, and there were deficiencies reported on 24 out of 25, according to CMS.

New goals for antipsychotics not unreasonable, leaders say

New goals for antipsychotics not unreasonable, leaders say

By

Providers may grumble about renewed pressure to lower the use of antipsychotics among long-term care residents with dementia, but the industry has an opportunity to be a leader, said LeadingAge President and CEO Larry Minnix.

Antipsychotics goal gets reset

Antipsychotics goal gets reset

By

Long-term care providers are being asked to reduce the use of antipsychotic medications among residents by 25% by the end of 2015, and 30% by the end of 2016.

Long-term care providers might need to change pain management to cut opioid use, MedPAC analyst says

By

Long-term care and other providers might have to alter their pain management practices if changes discussed at a recent Medicare Payment Advisory Commission meeting come to pass.

Nursing homes tend to administer high-risk medications to returning residents, study shows

By

Nursing homes may be ratcheting up high-risk medication use for certain residents who return to the facility after a stay in the hospital, according to recently published findings.

Reducing antipsych meds: 5 ways psychologists can help

Reducing antipsych meds: 5 ways psychologists can help

By

With the mandate to reduce the use of antipsychotics, many facilities are looking for alternative methods to address the behaviors often associated with dementia. There are several good resources available for training staff, including your consulting psychologist. Here's how he or she can help:

Antipsychotic use tied to acute kidney injury, increasing pressure on nursing home reduction efforts

By

Older people who take antipsychotic medications are at a markedly increased risk of acute kidney injury, according to newly published research findings out of Canada. The study further supports ongoing efforts to reduce the number of nursing home residents on these drugs.

Also in the news for August 7, 2014 . . .

Mild cognitive impairment quadruples risk of Alzheimer's ... UK health system testing antipsychotic medication patch ... Nursing home worker admits stealing from resident trust funds ... Genworth reviewing LTC insurance claims reserves

Dementia increases risk for  hospital readmission by 20%

Dementia increases risk for hospital readmission by 20%

By

Seniors are more likely to be rehospitalized within 30 days of discharge if they have dementia, and the risk increases if they are taking an antipsychotic medication, according to recently published research.

LTC achieves antipsych goal

By

After years of pushing, long-term care facilities have reduced their use of antipsychotic medication for dementia, according to an April report from the Centers for Medicare & Medicaid Services.

Aggression strongly signals pain only when dementia reaches advanced stages, researchers find

By

For a person with dementia, the link between aggressive behavior and physical pain is strong only in the condition's advanced stages, University of Florida researchers have found.

Public reporting of physical restraint use led to 36% increase in antipsychotic prescribing for dementia, researchers find

Public reporting of physical restraint use led to 36% increase in antipsychotic prescribing for dementia, researchers find

By

Public reporting of physical restraint use in nursing homes caused a spike in the use of antipsychotic medications to control residents' dementia symptoms, according to a recently published analysis. These results suggest that policymakers should consider unintended negative consequences of publicly reporting quality measures, the researchers emphasized.

Pharma company Teva to pay $27 million over charges of kickbacks to promote dangerous antipsychotic

By

Teva Pharmaceuticals and subsidiary IVAX LLC have agreed to a $27.6 million settlement over charges that they paid kickbacks to a psychiatrist for putting nursing home residents on the antipsychotic drug clozapine, the U.S. Department of Justice announced Tuesday.

CMS budget defines nursing home quality targets, requests an additional $50 million for surveys

CMS budget defines nursing home quality targets, requests an additional $50 million for surveys

By

The Centers for Medicare & Medicaid Services' proposed budget for fiscal year 2015 requests additional funds for survey activities and lists the agency's targets for nursing home quality measures.

Quick antipsychotic withdrawal OK: study

By

A small Belgian study of people with dementia on low-dose antipsychotics found that abrupt stoppage of the medication, rather than tapering, is a possible solution. Eighty-five percent of 40 patients who stopped abruptly were fine a month later.

Glaxo will stop paying doctors for speaking gigs in industry-leading change

By

Pharmaceutical giant GlaxoSmithKline will stop paying healthcare professionals to speak about its products, and will alter other marketing and compensation practices that are common in the industry but derided by critics, the company announced Tuesday.

Providers embracing technology bring in honors in second Tech Awards program

Providers embracing technology bring in honors in second Tech Awards program

By

The second annual McKnight's Long-Term Care News Excellence in Technology Awards begged the question: How can you compare to last year's storied winners?

SNFs progressing toward Quality Initiative goals, AHCA reports

By

More than 6,000 skilled nursing facilities achieved notable gains in the first year of the American Health Care Association's Quality Initiative, the provider association announced yesterday.

Golden LivingCenter-Indianapolis uses AlixaRx system to reduce antipsychotics, earning the SNF a top McKnight's tech award

Golden LivingCenter-Indianapolis uses AlixaRx system to reduce antipsychotics, earning the SNF a top McKnight's tech award

From reducing off-label use of antipsychotics to better antibiotic stewardship, medication management is at the forefront of today's long-term care challenges. And Golden LivingCenter-Indianapolis is in the vanguard of facilities tackling this challenge in innovative ways. For this, the skilled nursing facility received top honors in the McKnight's Excellence in Technology awards.

Biggest losers

Biggest losers

By

Providers reveal strategies for reducing unneccessary antipsychotics use for residents with dementia, and meeting industry-wide medication reduction goals

State News

State News

MASSACHUSETTS — An ongoing debate over nursing homes' use of antipsychotics flared in July during a meeting of the Joint Committee on Elder Affairs.

CMS and AHCA: Providers zeroing in on antipsychotic reduction target

CMS and AHCA: Providers zeroing in on antipsychotic reduction target

By

Nursing homes have made strides toward reducing antipsychotic medication use among residents with dementia, according to new figures from the Centers for Medicare & Medicaid Services and the American Health Care Association/National Center for Assisted Living.

Common antipsychotic fails as effective delirium treatment, study finds

By

Haloperidol, a common antipsychotic, is no more effective than a placebo in treating delirium in critically ill patients, according to a new study.

60 seconds with ... Alzheimer's expert Jason Karlawish, M.D.

60 seconds with ... Alzheimer's expert Jason Karlawish, M.D.

Q: The Alzheimer's Association annual conference took place in mid-July. As an expert in the disease, what did you find the most noteworthy takeaway?

Government agency calls off effort to assess antipsychotic use in nursing homes, watchdog group reports

By

A government investigation into nursing homes' antipsychotic prescribing practices will not move forward due to budget and staff cuts, according to nonprofit investigative news organization The Center for Public Integrity.

Analgesics account for most nursing home medication errors, researchers find

By

Most nursing home medication errors involve analgesics and sedatives, and these drugs are likely to account for errors regardless of how frequently they are administered, according to recently published research.

Providers refocus on 15% drug reduction

Providers refocus on 15% drug reduction

By

Skilled nursing providers fell short of reaching a 15% reduction in off-label antipsychotic use by the end of 2012, the American Health Care Association formally announced last month. However, AHCA did renew the goal for 2013, and members also performed better in the reductions than nursing providers overall.

Seroquel maker to pay $5.5M in latest settlement related to off-label use of the antipsychotic drug

By

Drugmaker AstraZeneca recently settled a lawsuit with the state of Kentucky over allegations of improperly marketing its atypical antipsychotic drug Seroquel. Under the settlement, the London-based pharmaceutical company will pay the Bluegrass State $5.5 million.

Woman gets 3 years in prison for giving psychotropic medication to nursing home residents

By

The former director of nursing at a California nursing home was sentenced Wednesday to three years in prison for administering powerful drugs to subdue residents.

Nursing home antipsychotic legislation set aside

Nursing home antipsychotic legislation set aside

By

The U.S. Senate did not approve legislation that would strengthen regulations for antipsychotic use in nursing homes, despite overwhelmingly passing a bill it was attached to on Thursday.

Don't miss any McKnight's news